Talk:CH391L/S13/Metagenomics & Bioprospecting: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
*'''[[User:Gabriel Wu|Gabriel Wu]] 18:03, 18 February 2013 (EST)''': We've talked a lot about DNA synthesis. I don't know if we need an entire talk on sequencing technologies (we certainly could, but may be beyond the scope), but, if anyone needs a little primer on it. It's a little dated, but still relevant on the fundamentals [http://www.nature.com/nbt/journal/v26/n10/full/nbt1486.html]. | *'''[[User:Gabriel Wu|Gabriel Wu]] 18:03, 18 February 2013 (EST)''': We've talked a lot about DNA synthesis. I don't know if we need an entire talk on sequencing technologies (we certainly could, but may be beyond the scope), but, if anyone needs a little primer on it. It's a little dated, but still relevant on the fundamentals [http://www.nature.com/nbt/journal/v26/n10/full/nbt1486.html]. | ||
**'''[[User:Jeffrey E. Barrick|Jeffrey E. Barrick]] 12:58, 20 February 2013 (EST)''':I'd say it's probably beyond the scope of our course to go too much into sequencing tech, but it's good stuff to know. Thanks for posting the link. | |||
*'''[[User:Kevin Baldridge|Kevin Baldridge]] 01:55, 19 February 2013 (EST)''':The introduction is great and really helpful. However there is a little bit of redundancy, the sentences at the ends of the first two paragraphs in particular. | *'''[[User:Kevin Baldridge|Kevin Baldridge]] 01:55, 19 February 2013 (EST)''':The introduction is great and really helpful. However there is a little bit of redundancy, the sentences at the ends of the first two paragraphs in particular. | ||
**'''[[User:Jeffrey E. Barrick|Jeffrey E. Barrick]] 12:58, 20 February 2013 (EST)''':Please finish merging in whatever additional content was there from last year's topic. You also need at least one more image. | |||
==Metabolic Engineering== | ==Metabolic Engineering== | ||
*'''[[User:Gabriel Wu|Gabriel Wu]] 18:22, 18 February 2013 (EST)''': The story of taxol is interesting and important. Unfortunately, it hasn't been as successful at commercialization--at least not yet. Another rather impressive story that so far has been more successful commercially is the microbial production of the antimalarial artemisinin. By expressing plant genes in yeast, researchers are able to economically produce large amounts artemisinin precursor. The most recent publication in this field is [http://www.pnas.org/content/109/3/E111.short here]. An older, but clearer explanation is [http://www.nature.com/nbt/journal/v21/n7/full/nbt833.html here]. | *'''[[User:Gabriel Wu|Gabriel Wu]] 18:22, 18 February 2013 (EST)''': The story of taxol is interesting and important. Unfortunately, it hasn't been as successful at commercialization--at least not yet. Another rather impressive story that so far has been more successful commercially is the microbial production of the antimalarial artemisinin. By expressing plant genes in yeast, researchers are able to economically produce large amounts artemisinin precursor. The most recent publication in this field is [http://www.pnas.org/content/109/3/E111.short here]. An older, but clearer explanation is [http://www.nature.com/nbt/journal/v21/n7/full/nbt833.html here]. | ||
**'''[[User:Jeffrey E. Barrick|Jeffrey E. Barrick]] 12:58, 20 February 2013 (EST)''':It would be interesting to go back and trace the discovery of those genes. | |||
*'''[[User:Gabriel Wu|Gabriel Wu]] 18:26, 18 February 2013 (EST)''': A short interesting article about the difference between microbial production (synthetic biology style) versus chemical synthesis. [http://www.nature.com/nature/journal/v492/n7428/full/492188a.html] | *'''[[User:Gabriel Wu|Gabriel Wu]] 18:26, 18 February 2013 (EST)''': A short interesting article about the difference between microbial production (synthetic biology style) versus chemical synthesis. [http://www.nature.com/nature/journal/v492/n7428/full/492188a.html] | ||
Revision as of 10:58, 20 February 2013
- Gabriel Wu 18:03, 18 February 2013 (EST): We've talked a lot about DNA synthesis. I don't know if we need an entire talk on sequencing technologies (we certainly could, but may be beyond the scope), but, if anyone needs a little primer on it. It's a little dated, but still relevant on the fundamentals [1].
- Jeffrey E. Barrick 12:58, 20 February 2013 (EST):I'd say it's probably beyond the scope of our course to go too much into sequencing tech, but it's good stuff to know. Thanks for posting the link.
- Kevin Baldridge 01:55, 19 February 2013 (EST):The introduction is great and really helpful. However there is a little bit of redundancy, the sentences at the ends of the first two paragraphs in particular.
- Jeffrey E. Barrick 12:58, 20 February 2013 (EST):Please finish merging in whatever additional content was there from last year's topic. You also need at least one more image.
Metabolic Engineering
- Gabriel Wu 18:22, 18 February 2013 (EST): The story of taxol is interesting and important. Unfortunately, it hasn't been as successful at commercialization--at least not yet. Another rather impressive story that so far has been more successful commercially is the microbial production of the antimalarial artemisinin. By expressing plant genes in yeast, researchers are able to economically produce large amounts artemisinin precursor. The most recent publication in this field is here. An older, but clearer explanation is here.
- Jeffrey E. Barrick 12:58, 20 February 2013 (EST):It would be interesting to go back and trace the discovery of those genes.
- Gabriel Wu 18:26, 18 February 2013 (EST): A short interesting article about the difference between microbial production (synthetic biology style) versus chemical synthesis. [2]
Human Microbiome Project (HMP)
- Gabriel Wu 17:43, 18 February 2013 (EST): The first major paper release of the Human Microbiome Project (HMP) has been published. There were two big papers in Nature in June, 2012 1, 2. These papers accompanied a coordinated release of about a dozen papers in various PLoS journals [3].
